MabVax Therapeutics Holdings, Inc. Announces $1.0 Million Equity Purchase Agreement
SAN DIEGO, Nov. 28, 2018 -- (Healthcare Sales & Marketing Network) -- MabVax Therapeutics Holdings, Inc. (OTC Pink: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the t... Biopharmaceuticals, Oncology, Venture Capital MabVax Therapeutics, monoclonal antibody, pancreatic cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Marketing | Pancreas | Pancreatic Cancer | Pharmaceuticals | Venture Capital